Swiss Luxury Stock News

Why ABB stock is drawing fresh attention after the LevelTen Energy deal ABB (SWX:ABBN) is back in focus after announcing a partnership and minority investment in LevelTen Energy, tying its electrification and energy management tools more tightly to global clean energy procurement. See our latest analysis for ABB. The LevelTen Energy announcement lands at a time when ABB's share price has gained clear momentum, with a 30 day share price return of 4.8% and a year to date share price return of...

Montana Aerospace (SWX:AERO) is back in focus after reporting second quarter and half year 2026 results, with higher sales, stronger net income and clearer balance sheet targets capturing investor attention. See our latest analysis for Montana Aerospace. The latest earnings release appears to have shifted sentiment around Montana Aerospace, with the 1 month share price return of 23.81% and 3 month share price return of 23.25% pointing to building momentum. This comes despite a year to date...

With Michael Burry comparing the AI-fuelled rally to past bubbles and the CAPE ratio sitting close to its late 1999 peak, investors are watching a market where optimism and risk sit side by side. Trading venues and options infrastructure stocks can sit right in the slipstream of that activity. This article looks at three stocks exposed to the current news narrative and explains why their stories might deserve a place on your watchlist. The three stocks below are only a starting sample, and...

In the second quarter and first half of 2026, Alcon Inc. reported higher sales and revenue year on year, but net income for the six-month period fell to US$189 million from US$526 million, with basic and diluted earnings per share from continuing operations both dropping to US$0.39 from US$1.06. Even as Alcon maintained its full-year 2026 net sales growth guidance of 5% to 7%, the combination of rising revenue, lower profitability, and mixed valuation signals has sharpened investor focus on...

VZ Holding AG recently reported its half-year 2026 results, posting net income of CHF 131.69 million, with basic earnings per share from continuing operations rising to CHF 3.34. The simultaneous increase in net income and diluted earnings per share to CHF 3.33 suggests that profitability improved even after accounting for potential share dilution. With net income higher than last year’s half-year level, we’ll now examine how this earnings improvement affects VZ Holding’s investment...

Shareholders will be ecstatic, with their stake up 35% over the past week following Komax Holding AG 's ( VTX:KOMN...

mobilezone holding ag closed at CHF13.76 on Friday after a weak stretch that left the stock down about 7% over the past month. The market looks cautious. The headline from H1 2026 is that mobilezone swung from the deep loss reported in H2 2025 to a modest profit, with basic earnings per share at CHF0.25 and net income of CHF10.855m on revenue of CHF127.174m. Short term traders are reacting to a small telecom retailer on the mend. Long term investors are weighing that profit against a balance...

Rising reports of violent homejackings around Lake Geneva are testing Switzerland’s image as a safe harbour for wealth, and that shift is drawing fresh attention to security and surveillance technology providers. When reputations and high end assets feel exposed, demand for better protection often moves quickly. This article walks through three stocks tied to these security themes and explains how the recent news could matter for their long term story. The stocks covered below are just a...

How Swisscom’s latest earnings update is shaping investor focus Swisscom (SWX:SCMN) drew fresh attention on 6 August 2026 after reporting half year results that combined lower sales of CHF 7,221 million with higher net income of CHF 669 million and basic EPS of CHF 12.92. See our latest analysis for Swisscom. Since the start of the year Swisscom’s share price has gained 10.36%, while the stock is down 5.47% over the past 90 days, and the 1 year total shareholder return of 14.85% points to...

Bell Food Group (SWX:BELL) drew fresh attention this week after reporting the best half year in its history, with CHF 2,413.3 million in sales and higher net income and earnings per share. See our latest analysis for Bell Food Group. The latest earnings news comes alongside a clear shift in Bell Food Group’s share price momentum, with a 7 day share price return of 12.64% and a 30 day share price return of 14.53%. However, the year to date share price return is still down 5.53% and the 1 year...

The market has happily paid up for VZ Holding, with the stock at CHF175.40 and a rich P/E of 29.3x versus far cheaper peers. Today's H1 earnings land into that optimism with a clear headline. Profitability stayed strong, with a trailing net margin of 37.6%, and fresh client money kept flowing, with CHF3,300m of net inflows. The sentiment test now is simple. Are investors rewarding a genuinely premium wealth manager, or stretching the valuation on earnings that grew more slowly than in recent...

Montana Aerospace walked into this earnings season with a reputation for high growth expectations and a rich 42.1x P/E, yet the stock now sits at CHF27.30 after a strong 30 day run of about 25%. The headline from this quarter is simple: profitability caught up with the story. Q2 2026 revenue reached €278.3m and net income from ongoing operations came in at €19.1m, helping lift trailing net profit margins to 4.2%. The key question for you now is whether this earnings power still justifies...

In August 2026, St. Galler Kantonalbank AG reported half-year results showing net interest income of CHF 190.17 million and net income of CHF 119.87 million for the period ended June 30, 2026, both higher than a year earlier. The simultaneous rise in net interest income and net income points to stronger core banking operations and tighter cost and risk control. We will now examine how this improvement in net interest income shapes St. Galler Kantonalbank’s broader investment narrative for...

The market has cooled on Kuros Biosciences over the past week, with the stock down about 5% even as the latest report marks the first profitable half year in the company’s history. That disconnect between a softer share price and a clear profitability milestone is the core sentiment test for investors today. H1 2026 brought total revenue of US$92.4m and net profit of US$4.4m, backed by a 13.6% adjusted EBITDA margin. For a high growth medtech that only recently crossed into the black, this...

Galenica (SWX:GALE) is back in focus after its half year 2026 results showed higher sales and revenue alongside lower net income, while the company reaffirmed its 2026 guidance for net sales and EBIT growth. See our latest analysis for Galenica. Galenica’s recent half year results and confirmed 2026 guidance come after a share price that is down 17.6% year to date to CHF81.1, while the 5 year total shareholder return of 31.1% points to a stronger longer term picture. Short term share price...

Thurgauer Kantonalbank stock has gone almost nowhere over the past week, yet the latest earnings quietly pushed the story a little further ahead. Net income over the last twelve months sits at CHF 162.967m while the P/E multiple is about 20.2x, above the European banks average. The real tug of war today is between that premium pricing and a net profit margin of 36.8% that slightly trails last year. The question for investors is whether this modest margin squeeze justifies any strong emotional...

Glarner Kantonalbank stock has been grinding higher in recent weeks, with a 3‑month gain in double digits. Today the focus sits squarely on what those earnings are doing to profitability. The headline is margins. Net profit margin for the last twelve months stands at 25%, compared with 22.7% a year earlier, which helps explain why the stock screens on investors’ radars even with a P/E of 13.4x. Short‑term traders may fixate on today’s price move. Longer term investors will likely pay more...

Restylane Shaype launch puts Galderma Group in focus Galderma Group (SWX:GALD) has drawn fresh investor attention after securing European Union approval for Restylane Shaype, a hyaluronic acid gel designed specifically for minimally invasive chin shaping and augmentation. See our latest analysis for Galderma Group. The Restylane Shaype approval lands at a time when Galderma Group’s share price has eased in the very short term, with the 1 day and 7 day share price returns declining 3.11% and...

Swiss Re (SWX:SREN) is drawing fresh attention after its H1 2026 results, with net income of US$2.831b and basic earnings per share of US$9.57 for the six months to June 30. See our latest analysis for Swiss Re. Swiss Re's share price has climbed over the past quarter, with a 90 day share price return of 14.82% and a year to date share price return of 7.15%. The 3 year total shareholder return of 93.41% highlights how long term holders have been rewarded, as recent earnings keep interest in...

Komax Holding shares closed at CHF78.70 on Friday, only modestly higher over the past week and month, which suggests investors came into these results cautiously optimistic but not euphoric. The earnings headline is simple and uncomfortable. The wiring automation specialist is still loss making, with a basic earnings per share loss of CHF0.96 in the first half and trailing twelve month losses that remain in the mid single digit millions of francs. The key issue now is valuation. The stock...

Alcon (SWX:ALC) is back in focus after its second quarter 2026 earnings report. The results showed higher sales and revenue but a much lower net income figure, giving investors mixed signals to digest. See our latest analysis for Alcon. The recent earnings announcement, maintained 2026 net sales growth guidance, and the RxSight collaboration have come alongside a 90 day share price return of 17.97%, although the 1 year total shareholder return is down 13.93%. If this mix of earnings and...

Temenos (SWX:TEMN) has drawn fresh attention after its Board of Directors approved a share repurchase program of up to CHF 100 million, with the buyback running until February 26, 2027. See our latest analysis for Temenos. The buyback news comes after a mixed period for Temenos, with the share price at CHF73.25 and a 7 day share price return of 5.40% signalling short term momentum. The year to date share price return is down 10.12% and the 5 year total shareholder return is down 43.34%. If...

ARYZTA (SWX:ARYN) has come into focus after reporting half year 2026 results that showed slightly lower sales and earnings. Investors are weighing what these updated figures mean for the stock. See our latest analysis for ARYZTA. ARYZTA's recent half year 2026 update comes after a tougher stretch for the stock, with the share price at CHF45.25 and the 30 day share price return down 18.32%. The 1 year total shareholder return is down 39.22%, which points to fading momentum as investors...

PolyPeptide Group’s share price closed at CHF44 on Thursday, exactly where Samsung Biologics has pitched its all cash tender offer at CHF44.31. The market is trading the stock as if the deal price already tells the whole story. The earnings print suggests a different perspective. The key development is the rise in profitability. Revenue in the first half of 2026 reached €236.6m and earnings before interest, tax, depreciation and amortisation were €49.1m, with an underlying margin near 19%...